comparemela.com

Latest Breaking News On - Biocon group biologics - Page 1 : comparemela.com

Viatris and Biocon Biologics Announce Prime Therapeutics Prefers First-Ever Interchangeable Insulin Biosimilar Semglee® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection on its National Formularies

Nov. 3, 2021 Viatris Inc. and Biocon Biologics Limited , a subsidiary of Biocon Ltd., are proud to confirm that Prime Therapeutics, a leading pharmacy benefit manager serving. | November 3, 2021

ValGenesis Collaborates with Biocon Biologics for Digital Validation Across Multiple Sites

ValGenesis Collaborates with Biocon Biologics for Digital Validation Across Multiple Sites News provided by Share this article Share this article SAN FRANCISCO, Dec. 15, 2020 /PRNewswire/  ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that the Equipment Commissioning and Qualification (C&Q) process (validation life cycle) at Biocon Biologics has been digitized leveraging the power of ValGenesis VLMS – the industry s most trusted electronic validation lifecycle management system. Biocon Biologics, a subsidiary of Biocon, is an integrated pure play biosimilars organization addressing patients needs across the world, including developed markets like the U.S., Canada, EU and Australia, through its partners.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.